The webcast was lackluster from a delivery of passion and excitement ...but...notwithstanding that...I'm disappointed at such a lack of response as far as volume and share price. However, I guess I'm grateful for the nice move from $.15 up to close to $.40 and if we don't drop I'll be happy.

I think that this will be a very climb up as we wait for news from the FDA breakthrough status...or....additional licensing agreements, especially something that relates to braincancer...